President Biden’s Lower Cost Prescription Drug Law Will Allow People with Medicare to Spread Out-of-Pocket Prescription Drug Costs into Monthly Payments.
President Biden’s Lower Cost Prescription Drug Law Will Allow People with Medicare to Spread Out-of-Pocket Prescription Drug Costs into Monthly Payments The Department of Health and Human Services , through the Centers for Medicare & Medicaid Services , continues to deliver on President Biden’s commitment to reduce the burden of high, upfront out-of-pocket prescription drug costs through the implementation of the President’s Inflation Reduction Act.
Today, CMS is releasing theregarding plan outreach and education for the Medicare Prescription Payment Plan, which aims to ensure that people with Medicare prescription drug coverage, especially those most likely to benefit, are aware of the payment option. Starting in 2025, the Medicare Prescription Payment Plan provides the option to people with Medicare prescription drug coverage to spread the costs of their prescription drugs over the calendar year rather than paying in full at the pharmacy counter each time they fill a prescription. People with Medicare must opt into the Medicare Prescription Payment Plan to utilize the new benefit. Notably, this payment option launches at the same time that all individuals with Medicare prescription drug coverage will begin to have their annual out-of-pocket prescription drug costs capped at $2,000, providing needed financial relief for high prescription drug costs. “The Medicare Prescription Payment Plan is one more way that President Biden is delivering on his promise of more predictable monthly costs for the American people,” said HHS Secretary Xavier Becerra. “No one should have to choose between paying for medicine or putting food on the table. Thanks to President Biden’s lower cost prescription drug law, the Inflation Reduction Act, fewer seniors and people with disabilities have to make such difficult decisions and instead can focus on improving their health.” “This new payment option provides people with high Rx spending the option to spread out the costs of their prescription drugs over the calendar year and eliminate the burden of paying the total out-of-pocket cost upfront,” said CMS Administrator Chiquita Brooks-LaSure. “CMS is continuing to implement the many important provisions of the Inflation Reduction Act to help people with Medicare access the prescriptions they need.” This final part two guidance complements CMS’ forthcoming national education and outreach efforts to engage interested parties, including Part D plans, pharmacies, providers, drug manufacturers, and beneficiary advocates, on program implementation. The goal of this effort is to provide the support and materials necessary to determine who may benefit from the program and guidance on how to educate them about this new payment option. This guidance updates and finalizes requirements proposed in the draft part tworeleased on February 29, is also accompanied by the release of the final Medicare Prescription Payment Plan model materials. Medicare Part D plans can use the model materials when communicating to Part D enrollees about the Medicare Prescription Payment Plan. “At CMS, we are working hard to empower and educate people with Medicare to make the best choices for their health and financial needs,” said Meena Seshamani, MD, PhD, CMS Deputy Administrator and Director of the Center for Medicare. “The Medicare Prescription Payment Plan complements other important changes to prescription drug coverage within the Inflation Reduction Act, and we encourage people with Medicare prescription drug coverage to look at this payment option and our other programs, such as Extra Help, to see what is right for them.” The Inflation Reduction Act is already helping to reduce the burden of high upfront out-of-pocket prescription drug costs for people with Medicare, including:Making Advisory Committee on Immunization Practices -recommended vaccines available at no cost for people with Medicare prescription drug coverage. . Expanding eligibility for the Extra Help program under Medicare Part D, which provides prescription drug coverage with no deductible, no premiums, and fixed, lowered copayments for certain medications to certain individuals. As of January 1, 2024, some enrollees now have their out-of-pocket drug costs capped at about $3,500. Additional savings arrive in 2025 when yearly Part D out-of-pocket costs will be capped at $2,000. https://www.cms.gov/files/document/fact-sheet-medicare-prescription-payment-plan-final-part-two-guidance.pdfSecretary Becerra Names Chief Competition Officer to Help Identify Areas to Promote Competition in Health Care New HHS Actions and Research Highlight How President Biden’s Administration is Lowering Prescription Drug CostsDisclaimer Policy: Links with this icon mean that you are leaving the HHS website.Linking to a non-federal website does not mean that HHS or its employees endorse the sponsors, information, or products presented on the website. HHS links outside of itself to provide you with further information. You will be bound by the destination website's privacy policy and/or terms of service when you follow the link.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
HHS Announces Cost Savings for 64 Prescription Drugs Thanks to the Medicare Rebate Program Established by the Biden-Harris Administration’s Lower Cost Prescription Drug LawSome people with Medicare will pay less for some Part B drugs if the drug’s price increased faster than the rate of inflation.
Read more »
Prescription Drug Misuse on the Rise: Examining the Worsening EpidemicThe US (particularly California, where drug overdose is still on the rise) is currently facing its largest prescription drug crisis in history; the COVID-19 pandemic largely intensified the process.
Read more »
Prescription drug prices rose nearly 40% over last decade, surpassing inflation rate, tracker showsThe data from GoodRx showed patients are having increased difficulty navigating insurance hurdles, including increased costs and more restrictions on covered drugs.
Read more »
Prescription drug prices soar nearly 40% over past decade, surpassing inflation, study findsIn 2024 alone, Americans have spent $21 billion on out-of-pocket prescriptions.
Read more »
FTC to Sue Prescription Drug Middlemen Over High Prices: ReportsJust three pharmacy benefit managers, Express Scripts, Caremark, and OptumRx, handle 80% of prescriptions in the U.S.
Read more »
The dire impact higher prescription drug costs are having on AmericansDuring my junior year of high school, I got the same question everyone got at that age: “what do you want to be when you grow up?”
Read more »